V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

Enovis Corporation Executive Compensation (FY25)

ENOV · Wilmington, DE · Executive and director compensation, fiscal 2022 to 2025
Data as of September 7, 2026Latest filing (8-K): May 19, 2026
304 figures on this page: 294 cited to the filing that reported them, 10 calculated from figures it prints. See the citations
Chief executive, fiscal 2025
◇
Damien McDonald
Median of the other named officers
$2,697,380
6 officers, excluding the chief executive
Latest say-on-pay support
=
May 19, 2026
Chief executive pay ratio
◇
To the median employee
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive of record: Matthew Trerotola → Damien McDonald
Say-on-pay support: 98.2% → 95.7% (2.5 points lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is Enovis Corporation's chief executive and what were they paid?
Total compensation for Damien McDonald, Chief Executive Officer, came to $9,242,161 in fiscal 2025.
What was Enovis Corporation's say-on-pay result?
Shareholders supported the say-on-pay proposal with 95.7% of votes cast including abstentions in favor at the meeting held May 19, 2026 for fiscal 2025.
Which companies are in Enovis Corporation's peer group?
The disclosed peer group includes Bio-Rad Laboratories, Bruker, DENTSPLY SIRONA, Envista Holdings and Haemonetics, among others.
What is Enovis Corporation's chief executive pay ratio?
For fiscal 2025, the company reported a chief executive pay ratio of 215:1, against median employee compensation of $44,633.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Matthew Trerotola
Chief Executive Officer
◇◇◇◇◇—◇◇
Brady Shirley
President and Chief Operating Officer
◇◇◇◇◇—◇◇
Christopher Hix
Former Executive Vice President and Chief Financial Officer
Departed during or after this year
◇◇◇—◇—◇◇
Daniel Pryor
Executive Vice President, Strategy and Business Development
◇◇◇◇◇—◇◇
Patricia Lang
Senior Vice President and Chief Human Resources Officer
◇◇◇◇◇—◇— not reconciled
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Matthew Trerotola
Executive Advisor – former Chief Executive Officer
◇—◇◇◇—◇◇
Daniel Pryor
Former Executive Vice President, Strategy and Business Development
◇—◇◇◇—◇◇
Phillip Berry
Chief Financial Officer
◇—◇◇◇—◇◇
Patricia Lang
Senior Vice President and Chief Human Resources Officer
◇—◇◇◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Matthew Trerotola
Chief Executive Officer
◇—◇—◇—◇◇
Daniel Pryor
EVP, Strategy and Business Development
◇—◇—◇—◇◇
Phillip Berry
SVP and Chief Financial Officer
◇—◇—◇—◇◇
Brady Shirley
Executive Advisor (former President and Chief Operating Officer)
Departed during or after this year
◇—◇—◇◇◇◇†
Patricia Lang
SVP and Chief Human Resources Officer
◇—◇—◇—◇◇
Bradley Tandy
SVP and Chief Legal Officer
◇—◇—◇—◇— not reconciled
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Matthew Trerotola
Executive Advisor (Former Chief Executive Officer)
Departed during or after this year
◇—◇—◇—◇◇
Damien McDonald
Chief Executive Officer
◇—◇—◇—◇◇
Phillip Berry
SVP and Chief Financial Officer
◇—◇—◇—◇◇
Daniel Pryor
Former EVP, Strategy and Business Development
Departed during or after this year
◇—◇—◇—◇◇
Terry Ross
Group President, P&R
◇—◇—◇—◇◇
Patricia Lang
SVP and Chief Human Resources Officer
◇—◇—◇—◇◇
Louis Vogt
Group President, Recon
◇—◇—◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Damien McDonaldOPTION◇——◇—◇◇
Damien McDonaldPSU◇◇◇—◇—◇
Daniel A. PryorPSU◇◇◇—◇—◇
Daniel A. PryorOPTION◇——◇—◇◇
Louis VogtPSU◇◇◇—◇—◇
Louis VogtOPTION◇——◇—◇◇
Matthew L. TrerotolaPSU◇◇◇—◇—◇
Matthew L. TrerotolaRSU◇——◇——◇
Patricia LangPSU◇◇◇—◇—◇
Patricia LangOPTION◇——◇—◇◇
Phillip Ben BerryOPTION◇——◇—◇◇
Phillip Ben BerryOPTION◇——◇—◇◇
Phillip Ben BerryPSU◇◇◇—◇—◇
Terry RossOPTION◇——◇—◇◇
Terry RossPSU◇◇◇—◇—◇
Fiscal 2022, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Damien McDonaldPSU◇◇——
RSU◇◇——
Patricia LangOption◇—◇—
PSU◇◇——
RSU◇◇——
Daniel PryorRSU◇◇——
Option◇—◇—
PSU◇◇——
Matthew TrerotolaOption◇—◇—
PSU◇◇——
Option◇—◇—
RSU◇◇——
RSU◇◇——
PSU◇◇——
Terry RossPSU◇◇——
Option◇—◇—
RSU◇◇——
Louis VogtRSU◇◇——
PSU◇◇——
Option◇—◇—
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Sharon Wienbar
Board chair
◇◇————◇
A. Clayton Perfall
◇◇————◇
Angela S. Lalor
◇◇————◇
Rajiv Vinnakota
◇◇————◇
Brady R. Shirley
◇◇————◇
Philip A. Okala
◇◇————◇
Barbara W. Bodem
◇◇————◇
Liam J. Kelly
◇◇————◇
Christine Ortiz
◇◇————◇
Damien McDonald and Matthew L. Trerotola served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Lead independent director premium◇
Audit committee chair◇
Nominating and governance chair◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Bio-Rad Laboratories BIO
  • Bruker BRKR
  • DENTSPLY SIRONA XRAY
  • Envista Holdings NVST
  • Haemonetics HAE
  • Hologic HOLX
  • ICU Medical ICUI
  • Integra LifeSciences Holdings IART
  • Masimo MASI
  • ResMed RMD
  • STERIS plc STE
  • Teleflex TFX
  • The Cooper Companies, Inc. COO
  • Zimmer Biomet Holdings, Inc. ZBH

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 19, 2026=◇◇◇
2024May 21, 2025=◇◇◇
2023May 20, 2024=◇◇◇
2022May 16, 2023=◇◇◇
2021June 7, 2022=◇◇◇
2020May 12, 2021=◇◇◇
2019May 21, 2020=◇◇◇
2018May 13, 2019=◇◇◇
2017May 17, 2018=◇◇◇
2016May 18, 2017=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Enovis Corporation files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Enovis Corporation disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Enovis Corporation sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether Enovis Corporation's disclosed peer group is defensible, who names Enovis Corporation back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
304 figures on this page: 294 cited to the filing that reported them, 10 calculated from figures it prints.
294 cited to the filing
10 calculated from the filing

Documents cited

  1. 0001493152-26-024438
  2. 0001493152-26-015302
    CEO PAY RATIO DISCLOSURE · DIRECTOR COMPENSATION · DIRECTOR COMPENSATION FOR 2025 · Grants of Plan-Based Awards for 2025 · and 2 more sections
  3. 0001193125-25-123977
  4. 0001193125-25-079083
    Summary Compensation Table
  5. 0001193125-24-144942
  6. 0001193125-24-088450
    Summary Compensation Table
  7. 0001193125-23-150464
  8. 0001193125-23-088156
    Summary Compensation Table
  9. 0001193125-22-172913
  10. 0001193125-21-162012
  11. 0001387131-20-005229
  12. 0001420800-19-000011
  13. 0001420800-18-000010
  14. 0001420800-17-000011
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Enovis Corporation executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/ENOV (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Enovis Corporation and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers Enovis Corporation discloses

The companies named in ENOV's own disclosed peer group.

Bio-Rad LaboratoriesBrukerDENTSPLY SIRONAEnvista HoldingsHaemoneticsHologicICU MedicalIntegra LifeSciences HoldingsMasimoResMedSTERIS plcTeleflexThe Cooper Companies, Inc.Zimmer Biomet Holdings, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  The Pay Desk · Methodology · Terms · Privacy